search
Back to results

LifeNet: Extracellular Matrix Graft in Rotator Cuff Repair

Primary Purpose

Rotator Cuff Tear

Status
Recruiting
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
ArthroFLEX ECM scaffold graft
Control
Crossover
Sponsored by
Gregory Gilot
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Rotator Cuff Tear focused on measuring Rotator Cuff Tear, Large Rotator Cuff Tear, Massive Rotator Cuff Tear, ECM, Extracellular Matrix, ArthroFLEX

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with a large (3-5 cm) to massive (>5 cm) rotator cuff tear who will be undergoing open or arthroscopic repair. The cuff tear size will be determined on pre-operative MRI and US.
  • Patients who are willing and able to provide written informed consent for their involvement in the study.
  • Patients who meet criteria for RCR surgery
  • Patients older than 18 years of age

Exclusion Criteria:

  • Patients with addiction to illegal drugs, solvents or alcohol who are actively using or have previously attempted and failed a treatment program.
  • Patients with bacteremia, a systemic infection, or infection of the surgical site.
  • All those who are prisoners.
  • Patients who are pregnant or nursing.
  • All those with a condition that may limit a patient's ability to finalize the study or that may cause an undue risk to the patient's health and well-being.

Sites / Locations

  • Cleveland Clinic FloridaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Active Comparator

Other

Arm Label

Control Group

Treatment Group

Crossover Group

Arm Description

Patients randomly assigned into the control group will undergo open or arthroscopic rotator cuff repair using the surgeon's standard practice. No ECM graft will be used.

Patients randomly assigned into the treatment group will undergo open or arthroscopic rotator cuff repair and the surgeon will use the ArthroFLEX® ECM graft to augment the repair. ECM scaffold grafts are indicated for the reinforcement of soft tissues repaired by sutures or suture anchors during tendon repair surgery, including rotator cuff.

Patients initially randomized to the control arm who cannot be repaired without an augmented graft will be followed for safety and remain in the study and put into a group for the intention to treat.

Outcomes

Primary Outcome Measures

Tendon healing
Success as defined by tendon healing after rotator cuff repair, as indicated based on MRI.
Comparison of healing by MRI vs US
Comparison of tendon healing will be assessed using US imaging modalities versus MRI.
Progress of tendon healing
Progress of tendon healing based on US will be used as predictive data for 1 year success (based on primary outcome)

Secondary Outcome Measures

Patient Outcomes: The American Shoulder and Elbow Surgeon Shoulder Score (ASES)
The ASES is standardized form for assessment of the shoulder. There are patient-self-evaluation and physician assessment sections. The patient self-evaluation section form contains visual analog scales for pain and instability and an activities of daily living questionnaire. The activities of daily living questionnaire is marked on a four-point ordinal scale that can be converted to a cumulative activities of daily living index. The physician assessment section assesses range of motion, specific physical signs, strength, and stability. A shoulder score can be derived from the visual analogue scale score for pain (50%) and the cumulative activities of daily living score (50%).
Patient Outcomes: The Western Ontario Rotator Cuff Index (WORC)
A disease-specific quality of life measurement tool for patients with rotator cuff disease. Patients will respond to by marking a scale with ranges between none and extreme. Information collected includes physical symptoms, such as pain and weakness levels in the shoulder, the impact of the patient's shoulder injury on their sports/recreational activities, work (inside or outside of the home), lifestyle/activities of daily living (ADL), and its emotional impact, such as frustration level, depression, and any worry/concern a patient might be about how their injury might affect their occupation.
Patient Outcomes: Measurement of Shoulder Activity Level
This activity scale was developed using established principles: item generation, item reduction, pretesting, and reliability and validity testing. The activity rating is a numerical sum of scores for five activities rated on a five-point frequency scale from never performed (0 points) to daily (4 points). Patients were scored on the following criteria: carrying an object 8 lb or heavier by hand, handling objects overhead, weight training with arms, swinging motion (ie, hitting tennis or golf ball), and lifting objects 25 lb or heavier. Two additional multiple choice questions provide a score assessing participation in contact and overhead sports. It can be used in conjunction with patient-based measures of shoulder outcome to define patient populations for cohort studies, and to assess activity level as a prognostic factor in patients with shoulder disorders. (Clin Orthop Relat Res. 2005 Oct;439:101-8.)
Patient Outcomes: Subjective Shoulder Value (SSV)
The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100%. (J Shoulder Elbow Surg. 2007 Nov-Dec;16(6):717-21.)
Patient Outcomes: Constant Score (CS)
C Constant and A Murley. This scoring system consists of four variables that are used to assess the function of the shoulder. The right and left shoulders are assessed separately. The subjective variables are pain and ADL (sleep, work, recreation / sport) which give a total of 35 points. The objective variables are range of motion and strength which give a total of 65 points. More information on the Constant Score can be found here: https://www.shoulderdoc.co.uk/article/9.

Full Information

First Posted
May 15, 2018
Last Updated
October 13, 2022
Sponsor
Gregory Gilot
Collaborators
LifeNet Health, The Cleveland Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT03551509
Brief Title
LifeNet: Extracellular Matrix Graft in Rotator Cuff Repair
Official Title
Extracellular Matrix Scaffold Graft Augmentation in Rotator Cuff Repair: a Prospective, Randomized, Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
July 1, 2018 (Actual)
Primary Completion Date
June 30, 2024 (Anticipated)
Study Completion Date
June 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Gregory Gilot
Collaborators
LifeNet Health, The Cleveland Clinic

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
This trial is to evaluate the effectiveness of the ArthroFLEX® ECM scaffold graph as an augment in rotator cuff repair surgery to reduce the failure rate of rotator cuff repairs for large and massive rotator cuff tears.
Detailed Description
This is a prospective, randomized, controlled, multi-center clinical trial to evaluate the effectiveness of an ECM scaffold graft to augment repair of a large/massive rotator cuff tear. The study will involve 70 patients. 35 patients will be randomly assigned to each arm of the study. Despite advances in surgical technology, repairs of large (3-5 cm) and massive (>5 cm) rotator cuff tears (RCT) fail between 20%-90% of the time [1]. Due to their size and increased structural involvement, large or massive RCT present a substantial challenge to orthopaedic surgeons. [16] The repairs tend to fail at the suture-tendon junction, which is due to several factors, including tension at the repair and quality of the tendon [1-2,5]. Full thickness tears are uncommon in younger patients, especially those less than forty years old and are usually traumatic in etiology. Younger patients also typically fair better following arthroscopic rotator cuff repair with fewer failures and more successful return to pre-injury level of function [16]. One strategy to augment repair of large to massive rotator cuff tears has been the development of biological scaffold materials, which are composed of extracellular matrix (ECM). The ECM composing the scaffolds are made from a number of tissues, including, but not limited to, small intestinal submucosa (SIS), dermis, and pericardium [3]. Studies to date include both prospective and retrospective in animal and human models, and include Restore, a porcine-derived SIS by DePuy Orthopaedics, GraftJacket, a human-derived, non-cross-linked dermis graft by Wright Medical Technology, and Zimmer Collagen Repair, a cross-linked porcine derived dermal graft made by Zimmer. Restore studies have shown no benefit and some even an increase in repair failure with recommendations not to use to augment repair. GraftJacket studies have shown a reduction in graft failure; however, several of the Restore and GraftJacket studies are limited by a lack of a control cohort. The Zimmer graft studies have conflicting results with both an improvement and no improvement in failure rates of repair. The prior studies listed are all in vivo; however, the majority are not randomized trials and thus do not have a control with which to compare data. In addition, some trials include open repairs. A lack of prospective, randomized, controlled, in vivo trials exist that evaluate the ability of the ECM scaffold graft augmentation in large to massive arthroscopic rotator cuff repairs to decrease the failure rate.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rotator Cuff Tear
Keywords
Rotator Cuff Tear, Large Rotator Cuff Tear, Massive Rotator Cuff Tear, ECM, Extracellular Matrix, ArthroFLEX

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
70 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Patients randomly assigned into the control group will undergo open or arthroscopic rotator cuff repair using the surgeon's standard practice. No ECM graft will be used.
Arm Title
Treatment Group
Arm Type
Active Comparator
Arm Description
Patients randomly assigned into the treatment group will undergo open or arthroscopic rotator cuff repair and the surgeon will use the ArthroFLEX® ECM graft to augment the repair. ECM scaffold grafts are indicated for the reinforcement of soft tissues repaired by sutures or suture anchors during tendon repair surgery, including rotator cuff.
Arm Title
Crossover Group
Arm Type
Other
Arm Description
Patients initially randomized to the control arm who cannot be repaired without an augmented graft will be followed for safety and remain in the study and put into a group for the intention to treat.
Intervention Type
Biological
Intervention Name(s)
ArthroFLEX ECM scaffold graft
Intervention Description
In patients receiving a graft, thru mini open technique the lateral portal incision will be extended vertically approximately 5-6 cm. A standard, deltoid-splitting, mini-open approach will then be performed, leaving the deltoid attachment to the acromion intact. For arthroscopic technique same method of fixation will be used below. The dermis graft will be sized and cut so as to cover the entire repair site in both medial-lateral and anterior-posterior dimensions.
Intervention Type
Procedure
Intervention Name(s)
Control
Other Intervention Name(s)
Surgery - no graft
Intervention Description
This group will undergo rotator cuff repair surgery, but will not receive the ECM scaffold graft.
Intervention Type
Biological
Intervention Name(s)
Crossover
Other Intervention Name(s)
Surgery - graft if necessary for repair
Intervention Description
Patients randomized to the control arm who cannot be repaired without an augmented graft will be followed for safety and remain in the study and put into a group for the intention to treat.
Primary Outcome Measure Information:
Title
Tendon healing
Description
Success as defined by tendon healing after rotator cuff repair, as indicated based on MRI.
Time Frame
As assessed 1 year postoperatively.
Title
Comparison of healing by MRI vs US
Description
Comparison of tendon healing will be assessed using US imaging modalities versus MRI.
Time Frame
As assessed 1 year postoperatively.
Title
Progress of tendon healing
Description
Progress of tendon healing based on US will be used as predictive data for 1 year success (based on primary outcome)
Time Frame
As assessed at 1 year postoperatively.
Secondary Outcome Measure Information:
Title
Patient Outcomes: The American Shoulder and Elbow Surgeon Shoulder Score (ASES)
Description
The ASES is standardized form for assessment of the shoulder. There are patient-self-evaluation and physician assessment sections. The patient self-evaluation section form contains visual analog scales for pain and instability and an activities of daily living questionnaire. The activities of daily living questionnaire is marked on a four-point ordinal scale that can be converted to a cumulative activities of daily living index. The physician assessment section assesses range of motion, specific physical signs, strength, and stability. A shoulder score can be derived from the visual analogue scale score for pain (50%) and the cumulative activities of daily living score (50%).
Time Frame
Through study completion (1 year after surgery). Specifically this assessment will be administered one time before surgery (during the preoperative examination) and then at every follow-up visit thereafter (6 wks, 3 mos, 6 mos, and 1 year after surgery).
Title
Patient Outcomes: The Western Ontario Rotator Cuff Index (WORC)
Description
A disease-specific quality of life measurement tool for patients with rotator cuff disease. Patients will respond to by marking a scale with ranges between none and extreme. Information collected includes physical symptoms, such as pain and weakness levels in the shoulder, the impact of the patient's shoulder injury on their sports/recreational activities, work (inside or outside of the home), lifestyle/activities of daily living (ADL), and its emotional impact, such as frustration level, depression, and any worry/concern a patient might be about how their injury might affect their occupation.
Time Frame
Through study completion (1 year after surgery). Specifically this assessment will be administered one time before surgery (during the preoperative examination) and then at every follow-up visit thereafter (6 wks, 3 mos, 6 mos, and 1 year after surgery).
Title
Patient Outcomes: Measurement of Shoulder Activity Level
Description
This activity scale was developed using established principles: item generation, item reduction, pretesting, and reliability and validity testing. The activity rating is a numerical sum of scores for five activities rated on a five-point frequency scale from never performed (0 points) to daily (4 points). Patients were scored on the following criteria: carrying an object 8 lb or heavier by hand, handling objects overhead, weight training with arms, swinging motion (ie, hitting tennis or golf ball), and lifting objects 25 lb or heavier. Two additional multiple choice questions provide a score assessing participation in contact and overhead sports. It can be used in conjunction with patient-based measures of shoulder outcome to define patient populations for cohort studies, and to assess activity level as a prognostic factor in patients with shoulder disorders. (Clin Orthop Relat Res. 2005 Oct;439:101-8.)
Time Frame
Through study completion (1 year after surgery). Specifically this assessment will be administered one time before surgery (during the preoperative examination) and then at every follow-up visit thereafter (6 wks, 3 mos, 6 mos, and 1 year after surgery).
Title
Patient Outcomes: Subjective Shoulder Value (SSV)
Description
The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100%. (J Shoulder Elbow Surg. 2007 Nov-Dec;16(6):717-21.)
Time Frame
Through study completion (1 year after surgery). Specifically this assessment will be administered one time before surgery (during the preoperative examination) and then at every follow-up visit thereafter (6 wks, 3 mos, 6 mos, and 1 year after surgery).
Title
Patient Outcomes: Constant Score (CS)
Description
C Constant and A Murley. This scoring system consists of four variables that are used to assess the function of the shoulder. The right and left shoulders are assessed separately. The subjective variables are pain and ADL (sleep, work, recreation / sport) which give a total of 35 points. The objective variables are range of motion and strength which give a total of 65 points. More information on the Constant Score can be found here: https://www.shoulderdoc.co.uk/article/9.
Time Frame
Through study completion (1 year after surgery). Specifically this assessment will be administered one time before surgery (during the preoperative examination) and then at every follow-up visit thereafter (6 wks, 3 mos, 6 mos, and 1 year after surgery).

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with a large (3-5 cm) to massive (>5 cm) rotator cuff tear who will be undergoing open or arthroscopic repair. The cuff tear size will be determined on pre-operative MRI and US. Patients who are willing and able to provide written informed consent for their involvement in the study. Patients who meet criteria for RCR surgery Patients older than 18 years of age Exclusion Criteria: Patients with addiction to illegal drugs, solvents or alcohol who are actively using or have previously attempted and failed a treatment program. Patients with bacteremia, a systemic infection, or infection of the surgical site. All those who are prisoners. Patients who are pregnant or nursing. All those with a condition that may limit a patient's ability to finalize the study or that may cause an undue risk to the patient's health and well-being.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ashley Valdes, BS
Phone
(954)299-5000
Email
valdesa4@ccf.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gregory J Gilot, MD
Organizational Affiliation
Cleveland Clinic Florida
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cleveland Clinic Florida
City
Weston
State/Province
Florida
ZIP/Postal Code
33331
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jillian King, BS
Phone
954-659-6227
Email
kingj19@ccf.org
First Name & Middle Initial & Last Name & Degree
Gregory J Gilot, MD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
20189415
Citation
Derwin KA, Badylak SF, Steinmann SP, Iannotti JP. Extracellular matrix scaffold devices for rotator cuff repair. J Shoulder Elbow Surg. 2010 Apr;19(3):467-76. doi: 10.1016/j.jse.2009.10.020. Epub 2010 Feb 26.
Results Reference
background
PubMed Identifier
16210577
Citation
Schlegel TF, Hawkins RJ, Lewis CW, Motta T, Turner AS. The effects of augmentation with Swine small intestine submucosa on tendon healing under tension: histologic and mechanical evaluations in sheep. Am J Sports Med. 2006 Feb;34(2):275-80. doi: 10.1177/0363546505279912. Epub 2005 Oct 6.
Results Reference
background
PubMed Identifier
18938117
Citation
Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater. 2009 Jan;5(1):1-13. doi: 10.1016/j.actbio.2008.09.013. Epub 2008 Oct 2.
Results Reference
background
PubMed Identifier
15383811
Citation
Sclamberg SG, Tibone JE, Itamura JM, Kasraeian S. Six-month magnetic resonance imaging follow-up of large and massive rotator cuff repairs reinforced with porcine small intestinal submucosa. J Shoulder Elbow Surg. 2004 Sep-Oct;13(5):538-41. doi: 10.1016/j.jse.2004.03.005.
Results Reference
background
PubMed Identifier
16757756
Citation
Iannotti JP, Codsi MJ, Kwon YW, Derwin K, Ciccone J, Brems JJ. Porcine small intestine submucosa augmentation of surgical repair of chronic two-tendon rotator cuff tears. A randomized, controlled trial. J Bone Joint Surg Am. 2006 Jun;88(6):1238-44. doi: 10.2106/JBJS.E.00524.
Results Reference
background
PubMed Identifier
17403801
Citation
Walton JR, Bowman NK, Khatib Y, Linklater J, Murrell GA. Restore orthobiologic implant: not recommended for augmentation of rotator cuff repairs. J Bone Joint Surg Am. 2007 Apr;89(4):786-91. doi: 10.2106/JBJS.F.00315.
Results Reference
background
PubMed Identifier
15736287
Citation
Zheng MH, Chen J, Kirilak Y, Willers C, Xu J, Wood D. Porcine small intestine submucosa (SIS) is not an acellular collagenous matrix and contains porcine DNA: possible implications in human implantation. J Biomed Mater Res B Appl Biomater. 2005 Apr;73(1):61-7. doi: 10.1002/jbm.b.30170.
Results Reference
background
PubMed Identifier
18375271
Citation
Bond JL, Dopirak RM, Higgins J, Burns J, Snyder SJ. Arthroscopic replacement of massive, irreparable rotator cuff tears using a GraftJacket allograft: technique and preliminary results. Arthroscopy. 2008 Apr;24(4):403-409.e1. doi: 10.1016/j.arthro.2007.07.033.
Results Reference
background
PubMed Identifier
18201655
Citation
Badhe SP, Lawrence TM, Smith FD, Lunn PG. An assessment of porcine dermal xenograft as an augmentation graft in the treatment of extensive rotator cuff tears. J Shoulder Elbow Surg. 2008 Jan-Feb;17(1 Suppl):35S-39S. doi: 10.1016/j.jse.2007.08.005.
Results Reference
background
PubMed Identifier
17939470
Citation
Soler JA, Gidwani S, Curtis MJ. Early complications from the use of porcine dermal collagen implants (Permacol) as bridging constructs in the repair of massive rotator cuff tears. A report of 4 cases. Acta Orthop Belg. 2007 Aug;73(4):432-6.
Results Reference
background
PubMed Identifier
16205147
Citation
Brophy RH, Beauvais RL, Jones EC, Cordasco FA, Marx RG. Measurement of shoulder activity level. Clin Orthop Relat Res. 2005 Oct;439:101-8. doi: 10.1097/01.blo.0000173255.85016.1f.
Results Reference
background
PubMed Identifier
29156071
Citation
Parnes N, Bartoszewski NR, Defranco MJ. Arthroscopic Repair of Full-Thickness Rotator Cuff Tears in Active Patients Younger Than 40 Years: 2- to 5-Year Clinical Outcomes. Orthopedics. 2018 Jan 1;41(1):e52-e57. doi: 10.3928/01477447-20171114-02. Epub 2017 Nov 21.
Results Reference
background
PubMed Identifier
23631883
Citation
Chung SW, Kim JY, Kim MH, Kim SH, Oh JH. Arthroscopic repair of massive rotator cuff tears: outcome and analysis of factors associated with healing failure or poor postoperative function. Am J Sports Med. 2013 Jul;41(7):1674-83. doi: 10.1177/0363546513485719. Epub 2013 Apr 30.
Results Reference
background
PubMed Identifier
26129871
Citation
Greenspoon JA, Petri M, Warth RJ, Millett PJ. Massive rotator cuff tears: pathomechanics, current treatment options, and clinical outcomes. J Shoulder Elbow Surg. 2015 Sep;24(9):1493-505. doi: 10.1016/j.jse.2015.04.005. Epub 2015 Jun 28.
Results Reference
background

Learn more about this trial

LifeNet: Extracellular Matrix Graft in Rotator Cuff Repair

We'll reach out to this number within 24 hrs